Richard Rutter

Chief Scientific Officer @ NRG Therapeutics

About

I am an experienced pharmacologist and biologist with a breath of knowledge and leadership experience of preclinical drug discovery. I am passionate about the discovery of novel medicines and have a track record of initiating, leading and progressing drug discovery programmes from inception through to the clinic. I have 20 years of drug discovery experience and am currently CSO at a startup biotech NRG Therapeutics Ltd. Prior to this role I was the CSO for a novel anti-infectives company, Auspherix, based in the Stevenage Bioscience Catalyst, UK.

Country

United Kingdom

City

Greater Cambridge Area

Industry

Pharmaceuticals

Skill

Drug Discovery, Pharmacology, Assay Development, Neuroscience, Cell Biology, Pharmaceutical Industry, Biochemistry, Biomarkers, Biotechnology, Drug Development, High Throughput Screening, In Vitro, Life Sciences, Lifesciences, Clinical Development, Molecular Biology, Cell, In Vivo

Experience

Chief Scientific Officer

NRG Therapeutics

2018-8 - Present · 8 yrs 2 mos

Cambridge, United Kingdom

Head of Biology

Myricx Bio

2021-10 - 2022-7 · 10 mos

Stevenage, England, United Kingdom

CSO

Auspherix

2016-11 - 2018-7 · 1 yr 9 mos

Stevenage Bioscience Catalyst

Drug Discovery Biologist

Consultant for Biotech and Life Science Sector

2016-1 - 2016-11 · 11 mos

Director of Biology, Neuroscience Drug Discovery

GSK

2009-11 - 2015-12 · 6 yrs 2 mos

Biopolis, Singapore

In my role as Biology Director and Head of Department at the GSK Neuroscience R&D unit in Singapore I lead a biology department comprising in vitro and in vivo pharmacology and neurobiology teams. The site was made up of 46 scientists including Chemistry and DMPK; with a remit to discover novel medicines for ALS, SMA and Huntington's Disease, and accountability for progressing programmes from inception to phase II POC.

Team Leader, Biochemistry and Pharmacology

GSK

2006-4 - 2009-11 · 3 yrs 8 mos

Biopolis, Singapore

I joined the GSK Neuroscience R&D unit and relocated to Singapore in April 2006 to lead the Biochemistry and Pharmacology team with a remit to lead the development of in vitro and in vivo assays to support in house lead optimisation programmes and to characterise the pharmacology of novel small molecules before testing in preclinical in vivo models of cognition.

Senior Research Biologist

Merck

2001-2 - 2006-3 · 5 yrs 2 mos

Harlow, United Kingdom

After completing my PhD studies I joined the Neuroscience Research Centre at Merck Sharp and Dohme, Harlow (UK) as a Research Biologist (Feb 2001- Jan 2003) and then a Senior Research Biologist (Jan 2003-Mar 2006). I supported a number of Neuroscience Drug Discovery programmes in various therapeutic areas including pain, anxiety and depression and schizophrenia.